Search

everythinglearnresearchcommunity

for

Search:↓

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Non-ablative Er:YAG laser effectively treats hair loss with high patient satisfaction and no side effects.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Higher blood sugar levels may lead to more severe hair loss in women.

Genetic factors could lead to personalized treatments for hair loss.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Early hair graying is often inherited and influenced by genetics, environment, and lifestyle, but treatment options are limited.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

A woman lost all her hair in one day, was diagnosed with a rare type of hair loss, and regrew it in 12 weeks with treatment.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Early hair greying may increase the risk of heart disease.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Androgenetic alopecia causes hair loss by shrinking hair follicles due to androgens, with the connection between the muscle and hair follicle determining if the loss is reversible.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.